Page last updated: 2024-11-04

sulfisoxazole and Corneal Neovascularization

sulfisoxazole has been researched along with Corneal Neovascularization in 2 studies

Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.

Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SABBAGH, M2

Other Studies

2 other studies available for sulfisoxazole and Corneal Neovascularization

ArticleYear
[TREATMENT OF TRACHOMA AND PANNUS WITH GANTRISIN].
    Annales d'oculistique, 1963, Volume: 196

    Topics: Adolescent; Child; Cornea; Corneal Neovascularization; Humans; Ophthalmic Solutions; Sulfisoxazole;

1963
[TREATMENT OF TRACHOMA AND PANNUS WITH GANTRISIN IN THE SERVICE D'OPHTALMOLOGIE DE LA FACULT'E DE M'EDECINE DE DAMAS].
    Revue internationale du trachome. International review of trachoma, 1965, Volume: 42

    Topics: Adolescent; Animals; Child; Computer Systems; Corneal Neovascularization; Drug Therapy; Lepidoptera;

1965